Overactive Bladder

  • Leslie Saltzstein WooldridgeEmail author



  1. 1.

    Discuss diagnosis, incidence, and assessment of overactive bladder.

  2. 2.

    Delineate treatments for OAB.

  3. 3.

    Describe the impact on quality of life for patients with overactive bladder.



Pelvic Floor Pelvic Floor Muscle Overactive Bladder Detrusor Overactivity Urge Incontinence 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, vanKerrebroeck P (2002) The standardization of terminology of lower urinary tract function report from the standardization sub-committee of the International Continence Society. Neurol Urodyn 21:167–178CrossRefGoogle Scholar
  2. Abrams P, Artibani W, Gajewski JB, Hussain I (2006) Assessment of treatment outcomes in patients with overactive bladder: importance of objective and subjective measures. Urology 68(2 Suppl):17–28. ReviewGoogle Scholar
  3. Abrams P, Anderson K, Birder L, Brubaker L, Cardozo L, Chapple C, Cottenden A (2010) Fourth international consultation on incontinence recommendations of the international scientific committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incont. Neurourol Urodyn 29:213–240CrossRefPubMedGoogle Scholar
  4. American Geriatrics Society (2012) Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 60(4):616–31. doi:  10.1111/j.1532-5415.2012.03923.x. Epub 2012 Feb 29
  5. BOTOX® Best practices for the treatment of overactive bladder patients (2014). Allergan, Inc., IrvineGoogle Scholar
  6. Bright E, Cotterill N, Drake M, Abrams P (2012) Developing a validated urinary diary: phase 1. Neurol Urodyn 31(5):625–633CrossRefGoogle Scholar
  7. Fowler CJ, Panicker JN, Drake M, Harris C, Harrison SC, Kirby M, Lucas M, Macleod N, Mangnall J, North A, Porter B, Reid S, Russell N, Watkiss K, Wells M (2009) UK consensus on the management of the bladder in multiple sclerosis. Postgrad Med J 85(1008):552–9. doi:  10.1136/jnnp.2008.159178. Review
  8. Freilich D (2015) Panel: management of refractory overactive bladder: what to do when third line therapies fail – session highlights. Taken from
  9. Fundamentals of SNM resource book: academia medical education (2013). MN Medtronic, MinneapolisGoogle Scholar
  10. Glazener C, Boachie C, Buckley B, Cochran C, Dorey G, Grant A, Hagen S (2011) Urinary incontinence in men after formal one-to-one pelvic-floor muscle training following radical prostatectomy or transurethral resection of the prostate (MAPS): two parallel randomized control trial. Lancet 378:328–337CrossRefPubMedGoogle Scholar
  11. Gormley EA, Lightner DJ, Burgio KL, Chai TC, Clemens JQ, Culkin DJ, Das AK, Foster HE Jr, Scarpero HM, Tessier CD, Vasavada SP (2012) American Urological Association; Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J Urol 188(6 Suppl):2455–63. doi:  10.1016/j.juro.2012.09.079. Epub 2012 Oct 24
  12. Gormley EA, Lightner DJ, Faraday M, Vasavada SP (2015) American Urological Association; Society of Urodynamics, Female Pelvic Medicine. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment. J Urol 193(5):1572–80. doi:  10.1016/j.juro.2015.01.087. Epub 2015 Jan 23. Review
  13. Gray M, Moore KN (2009) Urologic disorders adult and pediatric care. Elsevier, St. LouisGoogle Scholar
  14. Hashim H, Abrams P (2012) Overactive bladder syndrome and urinary incontinence, 1st edn. Oxford University Press, OxfordGoogle Scholar
  15. Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A (2009) An International Urogynecological Association (IUGA)/International Continence Society (ICS) Joint Report on the Terminology for Female Pelvic Floor Dysfunction. Neurol Urodyn 29:4–20Google Scholar
  16. Hulme JA (1998) Beyond Kegels Book II: a clinician’s guide to treatment algorithms and special populations. Phoenix Publishing, MissoulaGoogle Scholar
  17. Irwin DE, Milsom I, Hunskaar S et al (2006) Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the IPIC study. Eur Urol 50(6):1306–1315CrossRefPubMedGoogle Scholar
  18. Kay GG, Granville LJ (2005) Antimuscarinic agents: implications and concerns in the management of overactive bladder in the elderly. Clin Ther 27(1):127–38; quiz 139–40. ReviewGoogle Scholar
  19. Kerdraon J, Robain G, Jeandel C, Mongiat AP, Game X, Fatton B, Scheiber-Nogueira MC, Vetel JM, Mares P, Petit AC, Amareno G (2014) Impact on cognitive function of anticholinergic drugs used for the treatment of overactive bladder in the elderly-Abstract. Prog Urol 24(11):672–681. Taken from
  20. Kraus SR, Bavendam T, Brake T, Griebling TL (2010) Vulnerable elderly patients and overactive bladder syndrome. Drugs Aging 27(9):697–713CrossRefPubMedGoogle Scholar
  21. MacDiarmid S (2015) PTNS for overactive bladder: patient selection and technique. Urol Times. Feb 1, 2015. Available at
  22. MacDiarmid SA, Peters KM, Shobeiri SA, Wooldridge LS, Rovner ES, Leong FC et al (2010) Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder. J Urol 183(1):234–240CrossRefPubMedGoogle Scholar
  23. Miller DC, Saigal CS, Litwin MS (2009) The demographic burden of urologic diseases in America. Urol Clin North Am 36:11–27CrossRefPubMedPubMedCentralGoogle Scholar
  24. Newman DK, Wein AJ (2009) Managing and treating urinary incontinence, 2nd edn. Health Professions Press, BaltimoreGoogle Scholar
  25. Robinson D, Cardozo L (2011) Estrogens and the lower urinary tract. Neurourol Urodyn 30(5):754–757CrossRefPubMedGoogle Scholar
  26. Sammour ZM, Gomes CM, Barbosa ER, Lopes RI, Sallem FS, Trigo-Rocha FE, Bruschini H, Srougi M. (2009) Voiding dysfunction in patients with Parkinson’s disease: impact of neurological impairment and clinical parameters. Neurourol Urodyn 28(6):510–5. doi:  10.1002/nau.20681
  27. Shamliyan J, Wyman J, Kane R (2012a) Nonsurgical treatments for urinary incontinence in adult women: diagnosis and comparative effectiveness. Agency for Healthcare Research and Quality. Retrieved 26 Oct 2012, from
  28. Shamliyan T, Wyman JF, Ramakrishnan R, Sainfort F, Kane RL (2012b) Benefits and harms of pharmacologic treatment for urinary incontinence in women. Ann Intern Med 156(12):861–874CrossRefPubMedGoogle Scholar
  29. Staskin DR, Peters KM, MacDiarmid S, Shore N, deGroat WC (2012) Percutaneous tibial nerve stimulation: a clinically an cost effective addition to the overactive bladder algorithm of care. Curr Urol Rep 13(5):327–334CrossRefPubMedPubMedCentralGoogle Scholar
  30. McAninch JW, Lue TF (2013) Smith’s general urology, 18th edn. McGraw-Hill, New YorkGoogle Scholar
  31. Thomas LH, Cross S, Barrett J, French B, Leathley M, Sutton CJ, Watkins C (2009) Treatment of urinary incontinence after stroke in adults (Review). Retrieved 4 Nov 2012, from CINAHL (
  32. University of Michigan, A (2012) Voiding diary: what it’s for, how to fill it out. J Fam Pract 61(9):547–548Google Scholar
  33. Williams D (2012) Management of bladder dysfunction in patients with multiple sclerosis. Nurs Stand 26(25):39–46CrossRefPubMedGoogle Scholar
  34. Wing RR, Creasman JM, West DS, Richter HE, Myers D, Burgio KL, Franklin F (2010) Improving urinary incontinence in overweight and obese women through modest weight loss. Obstet Gynecol 116(2):284–292CrossRefPubMedPubMedCentralGoogle Scholar
  35. Wyman JF, Burgio KL, Newman DK (2009) Practical aspects of lifestyle modifications and behavioral interventions in the treatment of overactive bladder and urgency urinary incontinence. Int J Clin Pract 63(8):1177–1191CrossRefPubMedPubMedCentralGoogle Scholar
  36. Zinner NR, Mattiasson A, Stanton SL (2002) Efficacy, safety, and tolerability of extended-release once-daily tolterodine treatment for overactive bladder in older versus younger patients. J Am Geriatr Soc 50(5):799–807Google Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Mercy Health Bladder ClinicMuskegonUSA

Personalised recommendations